BioSpace News Archive

Nearly one year after charges were filed against former Genentech employees accused of stealing trade secrets to benefit JHL Biotech, the two companies have come to an agreement over the ill-gotten intellectual property – destruction.

Biopharma companies are working with diagnostic companies to develop companion diagnostic tests to go along with specific therapies, often cancer drugs.

Last week was a busy week for clinical trial results. Here’s a look at some of the top stories and reporting.

The SWOT Analysis is a key tool in the strategic planning process that life science professionals can apply not only to career planning, but to career marketing.

The importance of artificial intelligence and machine learning is ever-increasing in the world of drug development and AstraZeneca is bolstering its participation in the tech revolution by striking a deal with New York-based Schrodinger to use that company’s advanced computing platform to help accelerate drug discovery efforts.

Here are three reasons why you need to boast a little, and ways to do just that.

This week, Roche said it extended its tender-offer period for outstanding shares of Spark to Oct. 1 from Sept. 3.

In addition, Sumitomo Dainippon is acquiring an equity stake of more than 10% of Roivant shares.

In China, much like the United States, it is incredibly difficult to obtain a patent for a diagnostic method.

Kodiak Sciences Inc. announced that management will participate in the Morgan Stanley Global Healthcare Conference in New York, NY on Monday, September 9 at 4:50 p.m. Eastern Time.